# Blue Heron Capital

> Blue Heron Capital is a VC fund in Richmond backing Health Care and Software. See 51 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Richmond, United States
- Total investments: 51
- Last investment: Jul 2026
- Lead investor: 41%
- Last fund: Nov 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/blue-heron-capital/
- Website: http://www.blueheroncap.com

Blue Heron Capital is a VC fund in Richmond focused on Health Care and Software. Blue Heron Capital invests in small-cap growth equity companies in healthcare and tech-enabled business services. The company believes in acting as committed partners to build value for companies and returns for their investors. Their firm brings strategic capital, industry expertise and a powerful network to support companies.Blue Heron Capitalis an operationally focused investment firm based in Richmond, Virginia. The company firmly believes that people make the difference in building great companies. Therefore, Blue Heron Capital only invests in companies where they have deep, relevant experience and can play an active role in the oversight of the business.

## Contacts

5 contacts available for Blue Heron Capital. Shizune tracks 19 team members at Blue Heron Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/blue-heron-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 17 | 33% |
| Software | 15 | 29% |
| Information Technology | 10 | 20% |
| Medical | 5 | 10% |
| Cyber Security | 4 | 8% |

71 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 13 | 25% |
| Series B | 12 | 24% |
| Funding Round | 8 | 16% |
| Series C | 5 | 10% |
| Series D | 2 | 4% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Thomas G. Snead | Investor | 2 | https://shizune.co/investors/profile/thomas-g-snead |
| Andrew Tichenor | Co-Founder & Managing Partner | 1 | https://shizune.co/investors/profile/andrew-tichenor |
| Christine Lane | Controller | 0 | https://shizune.co/investors/profile/christine-lane |
| Dendy Young | Security Team | 1 | https://shizune.co/investors/profile/dendy-young |
| Gordon Crenshaw | Principal | 7 | https://shizune.co/investors/profile/gordon-crenshaw |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Buildforce | Buildforce is building the first-ever marketplace and career lifecycle platform for people in construction, starting with the electrical trade. Its end-to-end career platform enables people in the construction trades to maintain consistent work at fair pay and with the benefits of a W-2 employee. Since its launch in 2020, Buildforce has become thego-to partner helping dozens of construction contractors connect with the construction workforce. | $10M | Series A | Jul 28, 2026 |  |
| Ognomy Sleep | Ognomy Sleep provides virtual sleep apnea care services that connect patients with sleep medicine specialists through telehealth appointments, home-based sleep testing, and ongoing treatment support. The company offers a digital care platform designed to help diagnose and manage sleep apnea through consultations, at-home evaluations, andpersonalized therapy options. Ognomy Sleep supports treatments such as PAP therapy, oral appliance therapy, Inspire implant therapy, and weight management options related to sleep apnea care. The platform also works with healthcare providers through referral services that support patient coordination and follow-up care. | $20M | Series A | Jun 30, 2026 |  |
| Remission Medical | Remission Medical is a virtual rheumatology clinic that connects patients with board-certified, state-licensed rheumatologists specializing in autoimmune inflammatory conditions. The clinic addresses a full range of rheumatological conditions, including Rheumatoid Arthritis. Patients are seen exclusively via video visits, and the clinic has addedHIPAA-compliant texting to help move patients into remission status and keep them there. Remission Medical also partners with healthcare organizations to increase access to rheumatology care for adult patients. |  | Series A | Apr 13, 2026 |  |
| AnswersNow | AnswersNow is an app that revolutionized autism support by utilizing the use of technology. All of their clinicians are board-certified behavioral analysts. With thousands of hours of training, ongoing certifications, and master's level education requirements. | $40M | Series B | Jan 21, 2026 |  |
| Vend Park | Vend is focused on unifying access to parking facilities through technology. | $17.5M | Series A | Oct 03, 2025 |  |
| BlackCloak | BlackCloak's Concierge Cybersecurity & Privacy Platform protects C-Suite Executives and High-Net-Worth Individuals from hacking, privacy, financial, and reputational risks. BlackCloak protects its clients in their personal lives, as opposed to corporate devices, monitoring the executive/high-profile person and their family. Oursolution protects (1) their privacy, (2) their devices, (3) their home, and (4) their peace of mind with bespoke solutions for this specific audience. | $17M | Series B | Sep 17, 2024 |  |
| CSA Medical | CSA Medical provides cryotherapy systems. It offers CryoSpray Ablation system, which enables the physicians to freeze, destroy, and remove unwanted tissues, as well as transports liquid nitrogen that is passed through a standard endoscope. CSA Medical was formerly known as Crymed Technologies and changed its name to CSA Medical in April 2006.Thecompany was incorporated in 1993 and is based in Lutherville Timonium, Maryland. | $53M | Series D | Sep 09, 2024 |  |
| Redi.Health | Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to patients.Founded in 2021, the company is based inColumbus, Ohio, United States. | $14M | Series B | Feb 28, 2024 |  |
| Redi.Health | Redi.Health is a healthcare technology company that develops health management platforms for patients. The company aims to connect patients with chronic diseases to patient support programs. These programs are created in partnership with pharmaceutical manufacturers and are always free to patients.Founded in 2021, the company is based inColumbus, Ohio, United States. | $14M | Series B | Feb 28, 2024 |  |
| Proof Technology | Process Server Technology is a powerful web-based platform and mobile app that instantly connects law firms with independent process servers. | $30.4M | Series B | Jan 26, 2024 |  |

10 of 51 investments shown.

## Co-investors
- [3TS Capital Partners](https://shizune.co/investors/profile/3ts-capital-partners) — VC Fund, 4 deals together
- [Allos Ventures](https://shizune.co/investors/profile/allos-ventures) — VC Fund, 4 deals together
- [Blu Venture Investors](https://shizune.co/investors/profile/blu-venture-investors) — VC Fund, 4 deals together
- [First Analysis](https://shizune.co/investors/profile/first-analysis) — VC Fund, 4 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 4 deals together
- [M25](https://shizune.co/investors/profile/M25-VC) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Blue Heron Capital invest in?

Blue Heron Capital invests primarily in Health Care, Software and Information Technology startups, most often at Series A and Series B stage. Most of the 51 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Blue Heron Capital?

Public channels for Blue Heron Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Blue Heron Capital?

The team at Blue Heron Capital includes Thomas G. Snead (Investor), Andrew Tichenor (Co-Founder & Managing Partner) and Christine Lane (Controller), among 19 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co